Abstract:Cancer immunotherapy has achieved remarkable success over the past decade by modulating patients' own immune systems and unleashing pre-existing immunity. However, only a minority of cancer patients across different cancer types are able to benefit from immunotherapy treatment; moreover, among those small portions of patients with response, intrinsic and acquired resistance remains a persistent challenge. Because the tumor microenvironment (TME) is well recognized to play a critical role in tumor initiation, progression, metastasis, and the suppression of the immune system and responses to immunotherapy, understanding the interactions between the TME and the immune system is a pivotal step in developing novel and efficient cancer immunotherapies. With unique features such as low reagent consumption, dynamic and precise fluid control, versatile structures and function designs, and 3D cell co-culture, microfluidic tumor organoid-on-a-chip platforms that recapitulate key factors of the TME and the immune contexture have emerged as innovative reliable tools to investigate how tumors regulate their TME to counteract antitumor immunity and the mechanism of tumor resistance to immunotherapy. In this comprehensive review, we focus on recent advances in tumor organoid-on-a-chip platforms for studying the interaction between the TME and the immune system. We first review different factors of the TME that recent microfluidic in vitro systems reproduce to generate advanced tools to imitate the crosstalk between the TME and the immune system. Then, we discuss their applications in the assessment of different immunotherapies' efficacy using tumor organoid-on-a-chip platforms. Finally, we present an overview and the outlook of engineered microfluidic platforms in investigating the interactions between cancer and immune systems, and the adoption of patient-on-a-chip models in clinical applications toward personalized immunotherapy.

Organoids: new frontiers in tumor immune microenvironment research

Organoid Models of Tumor Immunology

3D Tumor Spheroid and Organoid to Model Tumor Microenvironment for Cancer Immunotherapy

Organoid models of the tumor microenvironment and their applications

Organoids: approaches and utility in cancer research

Immune organoids: from tumor modeling to precision oncology

Cancer organoids 2.0: modelling the complexity of the tumour immune microenvironment

Flourishing tumor organoids: History, emerging technology, and application

Organoid Modeling of the Tumor Immune Microenvironment

Tumor organoids: From inception to future in cancer research

Patient-Derived Tumor Organoids: New Progress and Opportunities to Facilitate Precision Cancer Immunotherapy

Advancing cancer research through organoid technology

Tumor organoids: applications in cancer modeling and potentials in precision medicine

The use of organoids in creating immune microenvironments and treating gynecological tumors

Organoid Models for Precision Cancer Immunotherapy

Organoids as an Enabler of Precision Immuno-Oncology

Immunotherapy discovery on tumor organoid-on-a-chip platforms that recapitulate the tumor microenvironment

Organoids: opportunities and challenges of cancer therapy

Organoid co-culture models of the tumor microenvironment promote precision medicine

Tumor Organoids: The Era of Personalized Medicine